PRODUCTS & SERVICES
CLS aims to accelerate Cannabis Extraction & Conversion through proprietary methods
while increasing quality & volume/output in a Compliance, Testing & Standardization
Environment.
Processing Revenue:
Arrange with growers to apply proprietary technology to generate cannabinoid concentrates which may be delivered in bulk or in individually-labeled retail-ready packages of oils, edibles, wax or shatter
Charge a flat fee by weight of the finished product or render our services in exchange for a percentage of the finished product which we will then sell to cannabis distributors or dispensaries.
Processing Facilities:
Lease buildings at which to construct processing facilities (Cost est. between US $1M - $3M) built within approx. 4-6
months after any applicable licensing and permitting requirements have been met
Subject to the availability of capital, open 2-3 processing facilities in the next 18-24 months (with the capacity to
process between 2,000 - 5,000 lbs of cannabis/month), for use by licensee or directly
Sale of Products and Brand Creation:
CLS may purchase unprocessed cannabis plants from growers, process the cannabis, then sell the resulting cannabinoid concentrates, such as oils, wax, edibles and shatter to distributors or dispensaries
Eventually, CLS may explore creation of its own brand of concentrates for consumer use
Consulting Services
CLS Consulting will offer consulting services, regarding a variety of areas such as licensure, growing, marketing and
distribution to cannabis-related businesses such as growers and dispensaries
COMPETITIVE ADVANTAGES
•
CLS’ patent pending proprietary process is expected to reduce growers’ costs and provide them with double the amount of Delta-9 THC compared to our competitors.
•
CLS expects to produce a much larger amount of Delta-9 THC from plants resulting in higher revenues.
•
The patent pending proprietary process is expected to result in market-changing product consistency.
•
CLS expects to produce cleaner, safer products as a result of the advanced testing that will be used at its
sophisticated labs.
•
CLS expects to provide one-stop, multi-state services to companies wishing to build private label brands
that deliver consistent products.
Market Drivers and Opportunity
•
Legalized cannabis market expected to grow from $7.1B in 2016
to $22.8B in 2020 (Arcview Group)
•
24 States Legalized for Medical
•
4 States & Washington DC Legalized for Recreational
Deployments
•
Licensing Partner’s Affiliate Completes Construction of Cannabis
Grow in Denver, Colorado
•
Expect to be Cash Flow Positive from this One Partner in 12
Months
People
•
Management & Insiders Invested $2.43M To-Date 75% Held by
Management & Insiders
Proprietary Technology & Methods
•
Proven/Validated Extraction & Conversion of Cannabinoids from
a Plant
•
Increased Yield, Higher Quality & more Consistency
•
Disrupting the Market by Increasing Output from the Plant &
Revenue for the Growers